(Q46679397)

24 December 2017

title

Measurement of apolipoprotein B as a screening test for identifying children with elevated levels of low-density lipoprotein cholesterol (English)

1 reference

24 December 2017

1 reference

Dennison BA

1

1 reference

24 December 2017

Kikuchi DA

2

1 reference

24 December 2017

Srinivasan SR

3

1 reference

24 December 2017

Webber LS

4

1 reference

24 December 2017

Berenson GS

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

24 December 2017

The Journal of Pediatrics

published in

1 reference

24 December 2017

volume

117

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

358-363

1 reference

24 December 2017

A general cardiovascular risk profile: The Framingham study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Consensus conference. Lowering blood cholesterol to prevent heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Atherosclerosis and apoproteins B and A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Relation of parental history of early myocardial infarction to the level of apoprotein B in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

The relation of apolipoproteins A-I and B in children to parental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

Radial immunodiffusion assay of apolipoprotein B in blood dried on filter paper--a potential screening method for familial type II hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

High-density lipoproteins: epidemiologic profile and risks of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981073-X

10.1016/S0022-3476(05)81073-X

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017